Abbvie Corporation v. Janssen Inc., 2014 FC 863 (Ustekinumab*)
Justice Brown - 2014-09-10
Read full decision. Automatically generated summary:
AbbVie sought a show cause order under Rule 467 of the Federal Courts Rules that Janssen be required to appear before a Judge of the Federal Court to hear proof of certain alleged acts of contempt of an order enjoining certain conduct issued after a patent infringement trial (see 2014 FC 55 and 2014 FC 489). Justice Brown held that "Prima facie [Janssen] undermined the dignity of this Court through its deliberate and wilful post-Injunction actions" and granted the order sought.
Decision relates to:
- T-1310-09 - ABBOTT LABORATORIES LIMITED ET AL v. JANSSEN-ORTHO INC.
- A-408-14 - which is an appeal from this decision